Considerations for people with diabetes during the Coronavirus Disease (COVID-19) pandemic

Sacks, Lori J.; Pham, Cecilia; Fleming, Nicola; Neoh, Sandra; Ekinci, Elif I

doi:10.1016/j.diabres.2020.108296

Cited by 25 publications

(28 citation statements)

References 75 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The potential impact on the medical supply chain was a global concern for PwD from the onset of the pandemic [39,40]. To ensure equitable access, some countries established policies to restrict overstocking [41,42]. Furthermore, to prevent shortage, global entities, including PAHO [43], recommended PwD to stock medicines for at least 2 to 3 months.…”

Section: Measures Beyond Physical Distancingmentioning

confidence: 99%

“…Furthermore, to prevent shortage, global entities, including PAHO [43], recommended PwD to stock medicines for at least 2 to 3 months. In addition to home delivery of medicines and supplies and/or provide them in quantities for 2-3 months, some nations or local health systems facilitated prescription refilling and allowed family members to collect drugs and supplies; all to reduce the need for PwD to leave their homes, protecting those with NCDs from additional exposure to the virus [16,30,33,38,41,44,45,46].…”

Section: Measures Beyond Physical Distancingmentioning

confidence: 99%

“…The lack of other options or the identification of telemedicine's potential led to its quick legal approval and reimbursement in several countries [33,45,46,49,51,52]. A variety of digital components were adopted in different places for diabetes care during the pandemic [41,53,54]. Some of them focused mainly on telephone calls.…”

Section: Transitioning From In-person To Telemedicine Carementioning

confidence: 99%

See 2 more Smart Citations

COVID-19 associated with diabetes and other noncommunicable diseases led to a global health crisis

Barone

Ngongo

Harnik

et al. 2021

Diabetes Research and Clinical Practice

View full text Add to dashboard Cite

COVID-19 has gravely threatened high-risk populations, such as people with diabetes and other noncommunicable diseases, leading to disproportionate hospitalizations, longer and repeated hospital stays and deaths among these individuals worldwide. It is well documented from previous outbreaks that diabetes increases the risk for poor outcomes due to SARS infection. In the present review, we bring evidence that country and global level health crisis caused by COVID-19 could have been avoided or highly minimized if measures to protect high-risk populations were implemented timely. In addition to general lockdowns, testing, tracing, isolation and hygiene measures, other specific interventions for diabetes and comorbidities management were key to allow the continuation of care services during the pandemic. These interventions included: teleconsultation, digital remote education/monitoring, e-prescription/medicine delivery options, mobile clinics, home HbA1c and albumin-creatinine tests. In this article, we recommend prompt actions to protect the most vulnerable groups, valuing knowledge and experiences from previous outbreaks and lessons learned during the COVID-19 pandemic, in order to shield communities, health systems and the global economy.

show abstract

Section: Measures Beyond Physical Distancingmentioning

confidence: 99%

Section: Measures Beyond Physical Distancingmentioning

confidence: 99%

Section: Transitioning From In-person To Telemedicine Carementioning

confidence: 99%

See 1 more Smart Citation

COVID-19 associated with diabetes and other noncommunicable diseases led to a global health crisis

Barone

Ngongo

Harnik

et al. 2021

Diabetes Research and Clinical Practice

View full text Add to dashboard Cite

show abstract

“…Different strategies have been implemented across the globe to effectively fight the pandemic. Australia and Portugal reported some of the most successful countrywide coordinated measures, implemented in partnership between the public and the private sectors [ [31] , [32] , [33] ]. Partnerships with communication and media channels were also shown to facilitate sharing of appropriate messages and guidance to the population in general, but also to those with diabetes and their caretakers [ 34 ].…”

Section: Discussionmentioning

confidence: 99%

“…As a matter of fact, they should receive medical assistance to adjust their therapy during the pandemic and be oriented to adapt healthy habits and behaviors [ 15 ]. Telemedicine, in its different forms, from teleconsultation to telediagnosis, should be considered [ 7 , 14 , 15 , [31] , [32] , [33] , [35] , [36] , [37] ], as well as mobile options for collecting samples at the individuals’ homes or using point-of-care equipment and, this way, avoid putting them at risk leaving their homes for in-person consultations or exams [ 18 , 38 , 39 ].…”

Section: Discussionmentioning

confidence: 99%

Decentralized COVID-19 measures in Brazil were ineffective to protect people with diabetes

Barone

Harnik

Chaluppe³

et al. 2020

Diabetes & Metabolic Syndrome: Clinical Research & Revi

View full text Add to dashboard Cite

Background and aims COVID-19 severity and mortality are elevated in individuals with diabetes. During the pandemic, interventions recommended globally for people with diabetes were to keep blood glucose on target whilst staying at home to curb the spread of the virus. In Brazil, similar measures were proposed. The aim of our observational study was to assess whether these measures achieved their objectives. Methods : An anonymous and untraceable survey was shared from April 22nd to May 4th. States with more than 30 respondents were included in the analysis and Fisher's exact test was performed to identify associations, with p < 0.05 considered significant. Results: Type 1 diabetes and female participants were prevalent, 60.76% and 76.12% respectively. 10 out of 26 states were included, in addition to the federal district (1562 responses). Only in three states (Bahia, Goiás and Pernambuco) less than 50% of the respondents experienced higher glycemia or higher variability during the pandemic. Goiás state, where almost half of the respondents (49.12%) have private insurance, presented the highest percentage of individuals receiving medicines for three months (35.48%) and one of the lowest percentages of blood glucose deterioration (47.17%). In the large states of Minas Gerais, Rio de Janeiro and São Paulo, consultations and/or lab exams were postponed by 37.14%, 34.33% and 40.88%, respectively. Conclusions: The decentralized measures implemented by states in Brazil left most people with diabetes unprotected. Many were forced to venture outside to collect or to purchase their monthly medical supplies and reported increased glycemic levels and/or variability.

show abstract

The Relationship of Spatio-temporal Patterns of Mortality of Diseases Associated with Malnutrition and Food Establishments in Mexico

Galeana-Pizaña,

Tapia-McClung,

Verdeja-Vendrell

et al. 2024

Lecture Notes in Geoinformation and Cartography

View full text Add to dashboard Cite

Considerations for people with diabetes during the Coronavirus Disease (COVID-19) pandemic

Cited by 25 publications

References 75 publications

COVID-19 associated with diabetes and other noncommunicable diseases led to a global health crisis

COVID-19 associated with diabetes and other noncommunicable diseases led to a global health crisis

Decentralized COVID-19 measures in Brazil were ineffective to protect people with diabetes

The Relationship of Spatio-temporal Patterns of Mortality of Diseases Associated with Malnutrition and Food Establishments in Mexico

Contact Info

Product

Resources

About